Your Cart ( 1 Item )

• Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials
  May 2016 | Volume 15 | Issue 5 | Original Article | 568 | Copyright © May 2016
  M. Alan Menter MD,^a Kim A. Papp MD,^b Jennifer Cather MD,^c Craig Leonardi MD,^d David M. Pariser MD,^e
  James G. Krueger MDM,^f Johannes Wohlrab MD,^g Mario Amaya-Guerra MD,^h Andrzej Kaszuba MD,ⁱ
  Oleg Nadashkevich MD,^j Tsen-Fang Tsai MD,^k Pankaj Gupta PhD,^l Huaming Tan PhD,^l
  Hernan Valdez MD,^m Lotus Mallbris MD,ⁿ and Svitlana Tatulych MD^l
  You will have 48 hours to download the full-text PDF

  Price

  24.95

  Term

  48 Hrs